| Name | BTRX-335140 |
|---|
| Description | BTRX-335140 (CYM-53093) is a potent and selective, orally active κ opioid receptor (KOR) antagonist, has antagonist activity for κOR, μOR and δOR with IC50 values of 0.8 nM, 110 nM, and 6500 nM, respectively.BTRX-335140 endows with favorable in vitro ADMET and in vivo pharmacokinetic profiles and medication-like duration of action in rats. BTRX-335140 can distribute well into the CNS. ADMET (absorption, distribution, metabolism, excretion, and toxicity) [1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 0.8 nM (κOR); 110 nM (μOR); 6500 nM (δOR)[1] |
| References |
| Molecular Formula | C25H32FN5O2 |
|---|---|
| Molecular Weight | 453.55 |
| Storage condition | 2-8°C |